Bali Muralidhar
Managing Partner, Chief Investment Officer
London, England, United Kingdom
73 investmentsBali Muralidhar is a Managing Partner, Chief Investment Officer based in London, England, United Kingdom. Bali Muralidhar has backed 73 companies, including Kesios Therapeutics, Spruce Biosciences and Amarin. Investment focus areas include Health Care, Women Founded and Life Science.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (73)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Kesios Therapeutics | — | — | — | — |
| 2 | Spruce Biosciences | — | — | — | — |
| 3 | Amarin | — | — | — | — |
| 4 | Syntaxin | — | — | — | — |
| 5 | CRISPR Therapeutics | — | — | — | — |
| 6 | Attenua | — | — | — | — |
| 7 | Broncus Technologies | — | — | — | — |
| 8 | Jasper Therapeutics | — | — | — | — |
| 9 | Synosia Therapeutics | — | — | — | — |
| 10 | X4 Pharmaceuticals | — | — | — | — |
| 11 | Kspine | — | — | — | — |
| 12 | Anjarium Biosciences | — | — | — | — |
Showing 1–12 of 73
Page 1 of 7
Access Full Contact Information
Get Bali Muralidhar's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required